A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

NCT02343536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse
Lymphoma, Follicular

Interventions

DRUG: Oral Azacitidine
DRUG: Rituximab
DRUG: cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Celgene